Bullish option flow detected in ImmunoGen with 1,670 calls trading, 1.4x expected, and implied vol increasing over 3 points to 67.49%. Sep-23 19 calls and Aug-23 20 calls are the most active options, with total volume in those strikes near 1,100 contracts. The Put/Call Ratio is 0.18. Earnings are expected on November 3rd.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on IMGN:
- ImmunoGen price target raised to $25 from $23 at Canaccord
- ImmunoGen price target raised to $26 from $21 at H.C. Wainwright
- ImmunoGen announces departure of Chief Medical Officer Anna Berkenblit
- ImmunoGen raises FY23 OpExp view to $350M-$365M from $320M-$335M
- ImmunoGen reports Q2 EPS (2c), consensus (14c)